Pediatric Gastroenterology, Hepatology & Nutrition

The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition (대한소아소화기영양학회)
권호 표지

Clinical Significance of Coagulation Screening Tests and Platelet Counts in Children Undergoing Endoscopy

소아에서 내시경 검사의 출혈 위험 예측 인자로서 혈액 응고 검사 및 혈소판 검사의 의의

  • Lee, Eun-Hye (Division of Gastroenterology and Nutrition, Department of Pediatrics, Seoul National University College of Medicine) ;
  • Yang, Hye-Ran (Division of Gastroenterology and Nutrition, Department of Pediatrics, Seoul National University College of Medicine) ;
  • Ko, Jae-Sung (Division of Gastroenterology and Nutrition, Department of Pediatrics, Seoul National University College of Medicine) ;
  • Seo, Jeong-Kee (Division of Gastroenterology and Nutrition, Department of Pediatrics, Seoul National University College of Medicine)
  • 이은혜 (서울대학교 의과대학 소아과학교실) ;
  • 양혜란 (서울대학교 의과대학 소아과학교실) ;
  • 고재성 (서울대학교 의과대학 소아과학교실) ;
  • 서정기 (서울대학교 의과대학 소아과학교실)
  • Received : 2010.02.09
  • Accepted : 2010.03.07
  • Published : 2010.03.30
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: The aim of this study was to assess the benefits of routine pre-endoscopy coagulation screening tests and platelet counts in Korean children. Methods: Between March 2004 and December 2009, children who underwent gastrointestinal endoscopy for the evaluation of various gastrointestinal symptoms were included. All of the subjects included in the study also underwent routine coagulation screening and platelet count determinations prior to endoscopy and biopsy. The clinical records and laboratory tests were retrospectively reviewed in all patients. Results: One hundred sixty-two of 1,476 (11%) patients who underwent endoscopy had abnormal results on pre-screening coagulation tests. Fourteen patients underwent coagulation factor assays due to abnormal clotting results in consecutive tests or due to clinical evidence of a bleeding tendency. Seven patients were diagnosed with factor XII deficiency, one patient was diagnosed with von Willebrand disease, one patient had von Willebrand disease and factor XII deficiency, and one patient was presumed to have mild hemophilia. The remaining 4 patients had normal results with the factor assays. The results of platelet counts were normal with the exception of 1 patient. No patient had significant bleeding during the endoscopic procedures, despite abnormal pre-endoscopic coagulation tests. Conclusion: Routine coagulation screening tests and platelet counts revealed abnormal results in some patients. Most of the patients with abnormal clotting were shown to have a factor XII deficiency, which had no significant associated bleeding tendencies; the other patients were diagnosed with hemophilia or von Willebrand disease. Therefore, although abnormal pre-endoscopic coagulation is not always related to significant bleeding complications, pre-endoscopic coagulation screening may be useful in some children in predicting the risk of bleeding tendency during endoscopic procedures.

목 적: 본 연구에서는 소아의 내시경 시술 전 출혈의 위험성을 예측하는 검사로 혈소판과 혈액 응고 검사의 임상적 의의를 평가하고자 하였다. 방 법: 2004년 3월부터 2009년 12월까지 분당서울대학교병원 소아청소년과 외래 및 입원 환자 중에서 위장관 내시경 검사를 시행 받은 소아청소년 환자의 의무기록과 혈소판 수치 및 혈액 응고 검사 결과들을 후향적으로 분석하였다. 결 과: 총 1,476건의 검사 결과, 혈소판 수치가 정상보다 낮은 경우는 1명이었고, PT INR만이 비정상으로 연장된 경우가 25건(1.7%)이었고, aPTT만 연장된 경우가 132건(9%)이었고, 둘 다 연장된 경우가 5건(0.3%)이었다. aPTT 결과가 비정상이었던 경우에 혈액 응고 인자 검사를 시행한 경우가 14건이었고, 이 중 혈액 응고인자 XII 결핍증으로 진단된 경우가 7명, 폰 빌레블란드 병으로 진단된 경우가 1명, 폰 빌레블란드 병과 혈액 응고 인자 XII 결핍증이 동시에 나타난 경우가 1명, 경증의 A형 혈우병이 의심된 경우가 1명이었으며, 나머지 4명은 정상이었다. 혈액 응고 질환으로 진단된 환자를 포함하여 내시경 시술을 받은 모든 소아 환자에서 의미 있는 출혈 합병증이 나타난 경우는 없었다. 결 론: 소아 내시경 사전 검사로 시행하는 혈액 응고검사에서 일부 이상 소견이 확인되더라도 실제 혈액 응고 질환으로 진단되는 경우는 드물고, 혈액 응고 질환으로 진단된 환자에서조차 내시경 시술에 의한 출혈 합병증이 나타나지 않았다. 따라서 내시경 시술 전에 모든 환자를 대상으로 혈액 응고 검사 및 혈소판 검사를 반드시 시행할 필요는 없을 것으로 여겨지며, 출혈 경향을 나타내는 과거력과 가족력이 있는 소아와 이전에 혈액 응고 검사를 한 번도 시행 받지 않았던 영유아 환자에서 내시경 시술 전에 혈액 응고 검사를 시행하는 것이 바람직할 것이다.

Keywords

References

  1. Levy MJ, Anderson MA, Baron TH, Banerjee S, Dominitz JA, Gan SI, et al. Position statement on routine laboratory testing before endoscopic procedures. Gastrointest Endosc 2008;68:827-32. https://doi.org/10.1016/j.gie.2008.06.001
  2. Ettingshausen CE, Halimeh S, Kurnik K, Schobess R, Wermes C, Junker R, et al. Symptomatic onset of severe hemophilia A in childhood is dependent on the presence of prothrombotic risk factors. Thromb Haemostasis 2001;85:218-20.
  3. Ljung R, Petrini P, Nilsson IM. Diagnostic symptoms of severe and moderate haemophilia A and B a survey of 140 cases. Acta paediatrica 1990;79:196-200.
  4. Pollmann H, Richter H, Ringkamp H, Jurgens H. When are children diagnosed as having severe haemophilia and when do they start to bleed? A 10-year single-centre PUP study. Eur J Pediatr 1999;158:166-70. https://doi.org/10.1007/PL00014347
  5. Kitchens CS. Occult hemophilia. Johns Hopkins Med J 1980;146:255-9.
  6. Venkateswaran L, Wilimas JA, Jones DJ, Nuss R. Mild hemophilia in children: prevalence, complications and treatment. J Pediatr Hematol Oncol 1998;20:32. https://doi.org/10.1097/00043426-199801000-00005
  7. Van Os EC, Kamath PS, Gostout CJ, Heit JA. Gastroenterological procedures among patients with disorders of hemostasis: evaluation and management recommendations. Gastrointest Endosc 1999;50:536-43. https://doi.org/10.1016/S0016-5107(99)70079-9
  8. Andrew M, Vegh P, Johnston M, Bowker J, Ofosu F, Mitchell L. Maturation of the hemostatic system during childhood. Blood 1992;80:1998-2005.
  9. Andrew M, Paes B, Milner R, Johnston M, Mitchell L, Tollefsen DM, et al. Development of the human coagulation system in the full-term infant. Blood 1987;70:165-72.
  10. Dzik WH. Predicting hemorrhage using preoperative coagulation screening assays. Curr Hematol Rep 2004;3:324-30.
  11. Suchman AI, Mushlin AI. How well does the activated partial thromboplastin time predict postoperative hemorrhage? JAMA 1986;256:750-3. https://doi.org/10.1001/jama.256.6.750
  12. Rohrer MJ, Michelotti MC, Nahrwold DL. A prospective evaluation of the efficacy of preoperative coagulation testing. Ann Surg 1988;208:554-7. https://doi.org/10.1097/00000658-198811000-00002
  13. Perez A, Planell J, Bacardaz C, Hounie A, Franci J, Brotons C, et al. Value of routine preoperative tests: a multicentre study in four general hospitals. Br J Anaesth 1995;74:250-6. https://doi.org/10.1093/bja/74.3.250
  14. Smetana GW, Macpherson DS. The case against routine preoperative laboratory testing. Med Clin North Am 2003;87:7-40. https://doi.org/10.1016/S0025-7125(02)00147-5
  15. Giles E, Walton-Salih E, Shah N, Hinds R. Routine coagulation screening in children undergoing gastrointestinal endoscopy does not predict those at risk of bleeding. Endoscopy 2006;38:508-10. https://doi.org/10.1055/s-2005-921041
  16. Burk CD, Miller L, Handler SD, Cohen AR. Preoperative history and coagulation screening in children undergoing tonsillectomy. Pediatrics 1992;89:691-5.
  17. Lowe GD, Forbes CD. Laboratory diagnosis of congenital coagulation defects. Clin Haematol 1979;8:79-94.
  18. Dzankic S, Pastor D, Gonzalez C, Leung JM. The prevalence and predictive value of abnormal preoperative laboratory tests in elderly surgical patients. Anesth Analg 2001;93:301-8.
  19. Yong DE, Lew SH, Lee JW, Park QE. A case of severe factror XII defiency. Korean Journal of Hemostasis and Thrombosis 1996;3:145-51.
  20. Stavrou E, Schmaier AH. Factor XII: What does it contribute to our understanding of the physiology and pathophysiology of hemostasis & thrombosis. Thrombosis Research 2010;125:210-5. https://doi.org/10.1016/j.thromres.2009.11.028
  21. Mannhalter C, Fischer M, Hopmeier P, Deutsch E. Factor XII activity and antigen concentrations in patients suffering from recurrent thrombosis. Fibrinolysis 1987;1:259-63. https://doi.org/10.1016/0268-9499(87)90046-4
  22. Nam YS, Kim NK, Lee SM, Kang MS, Oh DY, Cha KY. A study of factor XII defiency in recurrent spontaneous abortion. Korean Journal of Fertility and Sterility 2001;28:209-13.
  23. Nam YS, Kim IH, Yoon TK, Lee CN, Cha KY. A case of factor XII defiency which was found in recurrent spontaneous abrtion. Korean Journal of Fertility and Sterility 1999;26:271-4.
  24. Gordon EM, Donaldson VH, Saito H, Su E, Ratnoff OD. Reduced titers of Hageman factor (factor XII) in Orientals. Ann Intern Med 1981;95:697-700. https://doi.org/10.7326/0003-4819-95-6-697
  25. Cho YU, ChiHS, Choi SJ, Sim EH, Park CJ. The 46C/T polymorphism of coagulation factor XII in healthy Korean population and in patient with ischemic cerebrovascular disease. 2002;22:224-31.
  26. Halbmayer WM, Haushofer A, Schon R, Mannhalter C, Strohmer E, Baumgarten K, et al. The prevalence of moderate and severe Fxii (Hageman-Factor) deficiency among the normal population - evaluation of the incidence of Fxii deficiency among 300 healthy blooddonors. Thromb Haemostasis 1994;71:68-72.
  27. Barthels M, Edel J, Liese B, Karges HE. Additional factor XII (Hageman factor) deficiency in hemophilia A and in von Willebrand syndrome. J Mol Med 1982;60:303-9.
  28. Rodeghiero F, Castaman G, Dini E. Epidemiological investigation of the prevalence of von Willebrand's disease. Blood 1987;69:454-9.
  29. Sadler JE, Mannucci PM, Berntorp E, Bochkov N, Boulyjenkov V, Ginsburg D, et al. Impact, diagnosis and treatment of von Willebrand disease. Thromb Haemost 2000;84:160-74.